MedTrace Logo

COVID-19 in Patients With HIV

NCT04333953 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 412

Last updated 2022-05-23

No results posted yet for this study

Summary

Currently, limited data is available about patients with HIV in the context of the COVID-19 pandemic. People with HIV who have not achieved viral suppression through antiretroviral treatment may have a compromised immune system that leaves them vulnerable to infections and disease progression. However, little is known about the presentation and clinical outcomes of patients with HIV and SARS-CoV-2.

Our aim is to characterize the clinical presentation and disease course of COVID-19 in patients with HIV.

Conditions

Interventions

OTHER

No intervention

No intervention, observational study

Sponsors & Collaborators

  • University of Missouri-Columbia

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2020-07-01
Completion
2022-03-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04333953 on ClinicalTrials.gov